---
title: "FutureCrest Acquisition Corp. to Begin Separate Trading of Shares and Warrants"
description: "FutureCrest Acquisition Corp. will allow separate trading of its Class A ordinary shares and warrants from November 17, 2025. The shares and warrants will trade on the NYSE under \"FCRS\" and \"FCRS.WS,\""
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/265989710.md"
published_at: "2025-11-14T22:02:25.000Z"
---

# FutureCrest Acquisition Corp. to Begin Separate Trading of Shares and Warrants

> FutureCrest Acquisition Corp. will allow separate trading of its Class A ordinary shares and warrants from November 17, 2025. The shares and warrants will trade on the NYSE under "FCRS" and "FCRS.WS," respectively, while units will continue under "FCRS.U." Only whole warrants, allowing purchase of one Class A share at $11.50, will be tradable. Holders must contact brokers for separation.

FutureCrest Acquisition Corp. announced that, beginning November 17, 2025, holders of its units from the initial public offering may separately trade the Class A ordinary shares and warrants included in each unit. Each unit consists of one Class A ordinary share and one-quarter of a redeemable warrant. After separation, the Class A shares and warrants will trade on the NYSE under the symbols “FCRS” and “FCRS.WS,” respectively, while the units will continue trading under “FCRS.U.” Only whole warrants, each entitling the holder to purchase one Class A share at $11.50, will be tradable and exercisable. Holders wishing to separate their units must contact their brokers to coordinate with the company’s transfer agent. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Futurecrest Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-111010), on November 14, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [FCRS.U.US - FutureCrest Acquisition - Unit](https://longbridge.com/en/quote/FCRS.U.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| GLP-1 类药物可能会导致患者出现坏血病 | GLP-1 减肥药物，包括 Ozempic 和 Wegovy，与坏血病病例相关，这是一种由维生素 C 缺乏引起的罕见疾病。纽卡斯尔健康科学学院的 Clare Collins 的研究强调了使用这些药物的患者可能面临的营养不良风险。坏血病的症状 | [Link](https://longbridge.com/en/news/275772745.md) |
| 瑞银对 Amcor PLC Shs Chess 存托凭证（AMC）继续给予买入评级 | 瑞银分析师 Nathan Reilly 对 Amcor PLC 股票存托凭证（AMC）维持了买入评级，目标价为 91.25 澳元。Reilly 覆盖工业部门，其股票推荐的平均回报率为 13.1%，成功率为 69.77%。此外，TipRank | [Link](https://longbridge.com/en/news/276034399.md) |
| Mobilezone 将 MVNO 合同与 Sunrise 延长至 2029 年 | Mobilezone Holding AG 宣布与 Sunrise 提前延长其 MVNO 合同，涵盖其品牌 TalkTalk 和 Digital Republic，延续至 2029 年。该协议确保这两个品牌将继续使用 Sunrise 网络， | [Link](https://longbridge.com/en/news/276099690.md) |
| 据《华尔街日报》报道，高盛计划从董事会候选人标准中去除多样性因素 | 2 月 16 日（路透社）- 据《华尔街日报》周一报道，高盛正在准备从其董事会评估潜在候选人的标准中移除种族、性别认同、性取向及其他多样性因素，消息来源为知情人士。路透社尚未立即核实《华尔街日报》的报道 | [Link](https://longbridge.com/en/news/276088526.md) |
| 石药集团有限公司获得美国食品药品监督管理局的批准，可以在美国开展临床试验 | CSPC 制药集团有限公司已获得 FDA 批准，在美国进行其 GLP-1/GIP 受体双偏向激动剂 SYH2082 注射剂的临床试验。这种设计为每月一次的长效注射剂旨在提高患者的依从性，并支持持续的减重。前临床研究表明，在体重管理方面具有优 | [Link](https://longbridge.com/en/news/276050786.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.